Others have described that the CDKN2B-AS1 (antisense 1) variant is associated with coronary artery disease and type 2 diabetes (49–51), and variants in CCND1 have been associated in GWAS with type 2 diabetes, hemoglobin A1c, and BMI (51–53). This evidence concerns the gene CDKN2B and type 2 diabetes mellitus.